Viewing Study NCT02296918

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:03 AM

Ignite Modification Date: 2026-02-21 @ 10:34 AM

Study NCT ID: NCT02296918

Status: COMPLETED

Last Update Posted: 2025-12-19

First Post: 2014-11-19

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL

Sponsor: Acerta Pharma BV

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module